Literature DB >> 8880581

Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome).

P J Morrison1, N C Nevin.   

Abstract

Multiple endocrine neoplasia type 2B (MEN 2B), or the mucosal neuroma syndrome, is an autosomal dominant hamartoneoplastic syndrome. Features include multiple mucosal neuromas, phaeochromocytoma, medullary thyroid carcinoma, and Marfanoid body habitus with a characteristic dysmorphic facies. The gene responsible is the receptor tyrosine kinase (RET) proto-oncogene on chromosome 10. The mutational spectrum of MEN 2B is remarkably narrow, with over 95% of cases being caused by a single methionine to threonine substitution in the intracellular tyrosine kinase domain. Recent biochemical evidence suggests that this mutation alters the substrate specificity of intracellular signal transduction.

Entities:  

Mesh:

Year:  1996        PMID: 8880581      PMCID: PMC1050735          DOI: 10.1136/jmg.33.9.779

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Parental origin effects, genome imprinting, and sex-ratio distortion: double or nothing?

Authors:  C Sapienza
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

2.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

Authors:  H Donis-Keller; S Dou; D Chi; K M Carlson; K Toshima; T C Lairmore; J R Howe; J F Moley; P Goodfellow; S A Wells
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

3.  The genetics of retinoblastoma, revisited.

Authors:  A Naumova; C Sapienza
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

4.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

5.  cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.

Authors:  T Iwamoto; M Taniguchi; N Asai; K Ohkusu; I Nakashima; M Takahashi
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

6.  Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

Authors:  C Eng; D P Smith; L M Mulligan; M A Nagai; C S Healey; M A Ponder; E Gardner; G F Scheumann; C E Jackson; A Tunnacliffe
Journal:  Hum Mol Genet       Date:  1994-02       Impact factor: 6.150

7.  Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.

Authors:  G Romeo; P Ronchetto; Y Luo; V Barone; M Seri; I Ceccherini; B Pasini; R Bocciardi; M Lerone; H Kääriäinen
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

8.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.

Authors:  R M Hofstra; R M Landsvater; I Ceccherini; R P Stulp; T Stelwagen; Y Luo; B Pasini; J W Höppener; H K van Amstel; G Romeo
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

9.  Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

Authors:  K M Carlson; S Dou; D Chi; N Scavarda; K Toshima; C E Jackson; S A Wells; P J Goodfellow; H Donis-Keller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  Expression of the c-ret proto-oncogene during mouse embryogenesis.

Authors:  V Pachnis; B Mankoo; F Costantini
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  15 in total

Review 1.  Familial pediatric endocrine tumors.

Authors:  Sarinda Millar; Lisa Bradley; Deirdre E Donnelly; Dennis Carson; Patrick J Morrison
Journal:  Oncologist       Date:  2011-09-20

2.  Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population.

Authors:  Anna Znaczko; Deirdre E Donnelly; Patrick J Morrison
Journal:  Oncologist       Date:  2014-10-29

3.  The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status.

Authors:  Tabib Dabir; Steven J Hunter; Colin F J Russell; Damien McCall; Patrick J Morrison
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 4.  Oral Manifestations and Molecular Basis of Oral Genodermatoses: A Review.

Authors:  Kiran Kumar; A S Shilpasree; Meenakshi Chaudhary
Journal:  J Clin Diagn Res       Date:  2016-05-01

5.  Pulmonary Function in Patients With Multiple Endocrine Neoplasia 2B.

Authors:  Sarah Fuller; Jaydira Del Rivero; David Venzon; Maran Ilanchezhian; Deborah Allen; Les Folio; Alexander Ling; Brigitte Widemann; Joseph R Fontana; John Glod
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

6.  A family presenting with multiple endocrine neoplasia type 2B: A case report.

Authors:  Mahnaz Majidi; Vahid Haghpanah; Mahdi Hedayati; Patricia Khashayar; Mohammad Reza Mohajeri-Tehrani; Bagher Larijani
Journal:  J Med Case Rep       Date:  2011-12-20

7.  Multiple orbital neurofibromas, painful peripheral nerve tumors, distinctive face and marfanoid habitus: a new syndrome.

Authors:  D Babovic-Vuksanovic; Ludwine Messiaen; Christoph Nagel; Hilde Brems; Bernd Scheithauer; Ellen Denayer; Rong Mao; Raf Sciot; Karen M Janowski; Martin U Schuhmann; Kathleen Claes; Eline Beert; James A Garrity; Robert J Spinner; Anat Stemmer-Rachamimov; Ralitza Gavrilova; Frank Van Calenbergh; Victor Mautner; Eric Legius
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

Review 8.  Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.

Authors:  Laura M McDonell; Kristin D Kernohan; Kym M Boycott; Sarah L Sawyer
Journal:  Hum Mol Genet       Date:  2015-07-07       Impact factor: 6.150

Review 9.  10 rare tumors that warrant a genetics referral.

Authors:  Kimberly C Banks; Jessica J Moline; Monica L Marvin; Anna C Newlin; Kristen J Vogel
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

Review 10.  RET signaling in endocrine tumors: delving deeper into molecular mechanisms.

Authors:  Andrea Z Lai; Taranjit S Gujral; Lois M Mulligan
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.